| Alembic Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 533573 |
NSE Symbol : APLLTD |
P/E(TTM) : 39.84 |
|
ISIN Demat : INE901L01018 |
Div & Yield% : 1.22 |
EPS(TTM) : 22.59 |
|
Book Value(₹) : 267.35 |
Market Cap(₹Cr) : 17,688.72 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,796.24 | 1,494.17 | 1,570.64 | 1,406.09 | 1,580.35 | 1,475.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,796.24 | 1,494.17 | 1,570.64 | 1,406.09 | 1,580.35 | 1,475.56 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 11.49 | 7.79 | 13.21 | 15.46 | 28.93 | 3.15 |
| Total Income | 1,807.73 | 1,501.96 | 1,583.85 | 1,421.55 | 1,609.28 | 1,478.71 |
| Total Expenditure | 1,492.93 | 1,280.43 | 1,399.98 | 1,226.26 | 1,320.86 | 1,184.14 |
| PBIDT | 314.80 | 221.53 | 183.87 | 195.29 | 288.42 | 294.57 |
| Interest | 22.81 | 22.64 | 23.71 | 21.79 | 18.28 | 12.69 |
| PBDT | 291.99 | 198.89 | 160.16 | 173.50 | 270.14 | 281.88 |
| Depreciation | 75.64 | 73.37 | 68.60 | 69.69 | 70.12 | 68.68 |
| Tax | 36.99 | 22.00 | 16.22 | 18.00 | 34.24 | 37.01 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 179.36 | 103.52 | 75.34 | 85.81 | 165.78 | 176.19 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 10.67 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 179.36 | 103.52 | 75.34 | 85.81 | 155.11 | 176.19 |
| EPS (Unit Curr.) | 9.12 | 5.27 | 3.83 | 4.37 | 8.43 | 8.96 |
| EPS (Adj) (Unit Curr.) | 9.12 | 5.27 | 3.83 | 4.37 | 8.43 | 8.96 |
| Calculated EPS (Unit Curr.) | 9.13 | 5.27 | 3.83 | 4.37 | 8.43 | 8.96 |
| Calculated EPS (Adj) (Unit Curr.) | 9.13 | 5.27 | 3.83 | 4.37 | 8.43 | 8.96 |
| Calculated EPS (Ann.) (Unit Curr.) | 36.50 | 21.07 | 15.33 | 17.46 | 33.74 | 35.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 36.50 | 21.07 | 15.33 | 17.46 | 33.74 | 35.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.53 | 14.83 | 11.71 | 13.89 | 18.25 | 19.96 |
| PBDTM(%) | 16.26 | 13.31 | 10.20 | 12.34 | 17.09 | 19.10 |
| PATM(%) | 9.99 | 6.93 | 4.80 | 6.10 | 10.49 | 11.94 |